Daxor corporation announces significant expansion with five hospitals implementing its bva-100® blood volume diagnostic for heart failure patients

Oak ridge, tn, march 27, 2023 (globe newswire) --   daxor corporation (nasdaq: dxr), the global leader in blood volume measurement technology, today announces five new hospitals have implemented the company's bva-100 blood volume diagnostic for clinical use to guide fluid management in heart failure patients during the first quarter of 2023. the addition of these hospitals contributes to the significant growth of blood volume analysis (bva) sales, while providing additional validation for the use of bva in the clinical setting.
DXR Ratings Summary
DXR Quant Ranking